S100s and HMGB1 Crosstalk in Pancreatic Cancer Tumors
- PMID: 37627239
- PMCID: PMC10452588
- DOI: 10.3390/biom13081175
S100s and HMGB1 Crosstalk in Pancreatic Cancer Tumors
Abstract
Pancreatic cancer remains a disease that is very difficult to treat. S100 proteins are small calcium binding proteins with diverse intra- and extracellular functions that modulate different aspects of tumorigenesis, including tumor growth and metastasis. High mobility group box 1 (HMGB1) protein is a multifaceted protein that also actively influences the development and progression of tumors. In this study, we investigate the possible correlations, at the transcript level, between S100s and HMGB1 in pancreatic cancer. For this purpose, we calculated Pearson's correlations between the transcript levels of 13 cancer-related S100 genes and HMGB1 in a cDNA array containing 19 pancreatic cancer tumor samples, and in 8 human pancreatic cancer cell lines. Statistically significant positive correlations were found in 5.5% (5 out of 91) and 37.4% (34 of 91) of the possible S100/S100 or S100/HMGB1 pairs in cells and tumors, respectively. Our data suggest that many S100 proteins crosstalk in pancreatic tumors either with other members of the S100 family, or with HMGB1. These newly observed interdependencies may be used to further the characterization of pancreatic tumors based on S100 and HMGB1 transcription profiles.
Keywords: HMGB1; S100 protein; pancreatic cancer.
Conflict of interest statement
The authors declare no conflict of interest.
Similar articles
-
Intracellular HMGB1 as a novel tumor suppressor of pancreatic cancer.Cell Res. 2017 Jul;27(7):916-932. doi: 10.1038/cr.2017.51. Epub 2017 Apr 4. Cell Res. 2017. PMID: 28374746 Free PMC article.
-
High-mobility Group Box 1 and Mitogen-activated Protein Kinase activated Protein Kinase-2 Are Up-regulated in Gemcitabine-resistant Pancreatic Cancer Cells.Anticancer Res. 2015 Jul;35(7):3861-5. Anticancer Res. 2015. PMID: 26124331
-
Prognostic Values and Clinical Significance of S100 Family Member's Individualized mRNA Expression in Pancreatic Adenocarcinoma.Front Genet. 2021 Nov 3;12:758725. doi: 10.3389/fgene.2021.758725. eCollection 2021. Front Genet. 2021. PMID: 34804125 Free PMC article.
-
S100 family signaling network and related proteins in pancreatic cancer (Review).Int J Mol Med. 2014 Apr;33(4):769-76. doi: 10.3892/ijmm.2014.1633. Epub 2014 Jan 24. Int J Mol Med. 2014. PMID: 24481067 Review.
-
HMGB1, S100 proteins and other RAGE ligands in cancer - markers, mediators and putative therapeutic targets.Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2016 Mar;160(1):1-10. doi: 10.5507/bp.2016.003. Epub 2016 Feb 3. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2016. PMID: 26847418 Review.
Cited by
-
New therapeutic targets and mechanisms of papillary thyroid carcinoma identified by multi-omics analysis.Discov Oncol. 2025 May 8;16(1):691. doi: 10.1007/s12672-025-02550-y. Discov Oncol. 2025. PMID: 40338406 Free PMC article.
-
Investigating underlying molecular mechanisms, signaling pathways, emerging therapeutic approaches in pancreatic cancer.Front Oncol. 2024 Jul 17;14:1427802. doi: 10.3389/fonc.2024.1427802. eCollection 2024. Front Oncol. 2024. PMID: 39087024 Free PMC article. Review.
References
-
- Cancer.net. Pancreatic Cancer: Statistics. [(accessed on 20 May 2023)]. Available online: https://www.cancer.net/cancer-types/pancreatic-cancer/statistics#:~:text....
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases